• Quotes

  • NAVs

  • News

  • Messages

  • Opinions

  • Notices

  • Videos

Glenmark Pharma Homepage >> Moneycontrol.com >> Stocks >> Glenmark >> Pharmaceuticals >> Price/Quote, Highs, Lows, Volumes, Graphs, Bid, Offers, Historic Prices, Financials, Income, Results, Mutual Funds, Background, Management, News, Views, Actions, Interviews, Messages
Glenmark Pharma (BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035)
654.85 -13.25 (-1.98%)
BSE : Aug 07, 15:59
657.75 -12.15 (-1.81%)
NSE : Aug 07, 15:59
Open 668.90 Vol 39,547
Prev. Close 668.10
Intraday 52 Week
Highs 670.65 792.00
Lows 652.25 350.00
Open 667.00 Vol 127,864
Prev. Close 669.90
Intraday 52 Week
Highs 671.80 778.00
Lows 654.10 291.05
BID OFFER
Price 652.20 654.80
Quantity 50.00 8.00
BID OFFER
Price 0.00 657.75
Quantity 0.00 1,277.00
Mkt Cap 16,378.27 | * P/E 41.23 | Div 40.00 | * EPS (TTM) 15.88 | B/V: 33.59
Mkt Lot 1.00 | FV 1.00 | * EPS: As per stand alone adjusted profit after extra-ordinary items
Historic Prices & Returns of Glenmark Compare Price Performance With Peers
Price 1 week 2 week 1 month 3 month 6 month 9 month 1 year
BSE / NSE
661.50 657.45 605.50 643.60 495.80 490.90 324.65
-1.01% -0.4% 8.15% 1.75% 32.08% 33.4% 101.71%
Gain/Loss
On :
1 Week 1 Month 3 Month 1 Year 2 Year 3 Year
Historic Graph of Glenmark
From : To :
This page Auto Refreshes every 5 minutes
Messages Add to:
News on Glenmark
01-08 Glenmark files for USFDA ph-1 trials for GBR 500 BE
28-07 Expect domestic business to grow at 15-16%: Glenmark
Views on Glenmark

No Views in the last 7 days

Action on Glenmark
01-08 Glenmark Pharma in poor health
21-07 Glenmark Pharma continues to gain
Interviews on Glenmark
09-07 Earnings season to be good for pharma sector this quarter  
on Glenmark
Buy, Sell or Hold?- 58 opinions
1 boarder queriesAnswer now
Have a tip or opinion? Post your view

Messages on Glenmark
Continues to be Strong
Dear freinds,
please find below th...
View Comment                  Post Message
BSE/NSE Notices - Glenmark
Financials of Glenmark Quarterly Annual
Income Statement (Jun '08) (Mar '08)
Net Sales 193.98 1372.69
Other Income 0.44 20.05
PBDIT 47.66 501.76
Net Profit 56.84 389.02
Profit & Loss | Half Yearly Results | Quarterly Results |
Dividends | Bonus | Rights | Splits | Locations
Balance Sheet
Total Share Capital 24.01
Net Worth 450.16
Total Debt 907.48
Net Block 276.92
Investments 139.10
Net Current Assets 785.34
Total Assets 1357.66
Balance Sheet | Finished Goods | Raw Materials
Mutual Funds Holding - Glenmark
Scheme Name No. of shr
1,585,778
403,732
363,483
358,873
348,927
Are MFs buying or dumping Glenmark
Are fund managers betting on Pharmaceuticals sector
Groups: Pharmaceuticals
Company Last Price Market Cap
1,446.55 29,960.42
503.95 18,809.32
227.45 17,679.49
608.80 10,245.94
1,126.30 9,540.10
Compare with its peer group stocks on
Price Market Cap. Net Sales
Net Profit Total Assets
Simple Moving Averages
Days BSE NSE
30 636.95 637.03
50 647.93 648.23
150 575.74 576.16
200 556.94 557.30
Has Glenmark made any Bar Patterns today?
Has Glenmark made any Candlestick Patterns today?
Company Facts - Glenmark
Registered Address
B/2, Mahalaxmi Chambers
22, Bhulabhai Desai Road
Mumbai
Maharashtra
400026
Tel : 022-56549999
Fax : 022-23512177/23519652
Email : webmaster@glenmarkpharma.com
Website :
http://www.glenmarkpharma.com
Registrars
Karvy Computershare Private Ltd "Karvy House"
46, Avenue 4,
Street No. 1
Banjara Hills
Tel : 23312454, 23320251/751/752
Fax : 23311968
Email : mailmanager@karvy.com
Website :
www.karvy.com
 Intra Day Block Deals | Research Reports | Company Background | Listing Info
 Search all bulk deals in Glenmark Pharma
Management - Glenmark
Gracias Saldanha Non Executive Chairman
Glenn Saldanha Managing Director
A S Mohanty Director
Rajesh V Desai Director
B E Saldanha Director
J F Ribeiro Director
N B Desai Director
Cheryl Pinto Director
M Gopal Krishnan Director
Sridhar Gorthi Director
Type
S Glenmark
SMS to 52622 you
will receive the latest quote on both BSE & NSE.
Announcements
Board Meetings
AGM/EGM
Bonus
Rights
Splits
Dividends
Information
Company History
Background
Board of Directors
Capital Structure
Listing Info
Locations
Bulk Deals
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Half Yearly Results
Nine Monthly Results
Yearly Results
Cash Flow
Annual Report
Directors Report
Chairman's Speech
Auditors Report
Notes to Accounts
Finished Goods
Raw Materials
Peer Comparison
Price
Price Performance
Market Cap
Net Sales
Net Profit
Total Assets

Feedback

Chat

Prakash Gaba

Technical Analyst ,

(08 Aug- 15:30hrs)

How to be an effective trader?  

Upcoming Chat Schedule »

Previous Chat Transcripts »

Poll

With Rs 1,800 cr of buying yesterday, has the FII trend turned around?

Yes No

Newsletter

Keep in touch with News day & night. Subscribe to:

Mobile Services

Want us to track your stocks 24x7?

Subscribe to our Stock Messaging System

Get news on the move SMS to 52622

  • SMS M for Market News
  • SMS B for Latest Business News
  • SMS S (stock name) for latest news